Healthcare ❯ Pharmaceuticals

Prescription Medications

Regulations Drug Abuse Illicit Drugs Controlled Substances Weight Loss Drugs Diabetes Treatment E-Prescriptions Drug Pricing Drug Regulations Stimulant Medications Delivery Services Psychotropic Medications Online Pharmacies Abortion Pills Erectile Dysfunction Treatments Illegal Drug Use Abortifacients Statins Illegal Sales Injectable Medications Fraudulent Prescriptions Opioids Antiretroviral Drugs Opioid Crisis Addyi Market Regulations GLP-1 Drugs Access to Medications Sleep Aids Drugstore Pharmacy Weight Management Regulatory Issues Cost Reduction Emergency Contraceptives Stimulants Abortion Medications Proton Pump Inhibitors Illicit Use COVID-19 Treatments Sildenafil and Tadalafil Illegal Distribution Community Health Anxiolytics Benzodiazepines Anti-epileptics Patient Costs Over-the-Counter Drugs Ivermectin Drug Safety Risks of Prolonged Use Oncology Safety Risks Diabetes Treatments Pricing Illegal Drug Trade Decline of Neighborhood Pharmacy Cost Comparison Debt and Settlements Drug Trafficking Obesity Treatment App-based Delivery Regulatory Compliance

Ex-North Texas Principal Charged Over Alleged Sale of GLP-1 Weight‑Loss Drugs

The case highlights gaps in school hiring checks that could prompt tighter vetting of educators.

Older Adults With Obesity Now Match Peers’ Blood Pressure and Cholesterol

Verrica Reports $5 Million Q1 Revenue as Wycanth Grows and Phase 3 Wart Program Advances

New Adult Stimulant Prescriptions in Ontario More Than Doubled After 2020, CMAJ Study Finds

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65

Jury Trial Set for Henderson Man Accused of Smuggling Misbranded Erectile Dysfunction Drugs

Teen ADHD Stimulant Prescriptions Peak as Nonmedical Use Falls to New Low